CommercialPrior AuthLow impact
Noritate 1% (metronidazole cream)
Blue Cross & Blue Shield of Mississippi·MS · Dermatology, Family Medicine, Internal Medicine·Medical Policy
Effective date
Feb 24, 2026
We identified it
Jun 20, 2026
Summary
BCBS Mississippi updated their prior authorization policy for Noritate 1% (metronidazole cream) for rosacea treatment. The policy now removes Rosadan from the list of required formulary alternatives and clarifies that samples cannot be used to satisfy step therapy requirements.
Action Required
By February 24, 2026: Billing team should update prior authorization documentation for Noritate 1% prescriptions to ensure patients have documented failure of TWO formulary topical metronidazole agents (excluding Rosadan). Verify rosacea diagnosis is documented in patient records. Note that drug samples cannot be used to meet step therapy requirements.